Thu, 1 October, 14:30-16:00
Chairs:
- MUNIX in ALS: Linking Motor Neuron Loss to Clinical Phenotype and Disease Spread (F. Schöberl, LMU)
- Peptidomic and proteomic analyses identify MYL1 as a novel biomarker candidate for ALS (Besnik Muqaku, DZNE Ulm)
- Sweat Gland TDP-43 Pathology Precedes Symptom Onset in Amyotrophic Lateral Sclerosis (K. Hanna, Glasgow)
- Biomarkers for Amyotrophic Lateral Sclerosis beyond Neurofilaments (S. Michels, Ulm)
- NULISA-Based Biomarker Signatures Across the ALS–FTD Spectrum: Insights from the DZNE DESCRIBE Cohort (A. Schneider, Bonn)
- From movement videos to objective outcome measures: challenges and opportunities for motor neuron disease (M. Friedrich, Ulm)